Aegerion Pharmaceuticals Inc.
Q2 2016 13F Holders
Symbol
AEGR
CUSIP
00767E102
Type
Equity
Class
COM
Num filings
82
Total reported value, excl. options
$38.5 M
Compare 2016 Q2 to
2016 Q3
2016 Q1
2015 Q4
2015 Q3
2015 Q2
2015 Q1
2014 Q4
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type